Oral Ibuprofen and Ductus Arteriosus in Premature Infants: A Randomized Pilot Study

ABSTRACT

The purpose of this study was to evaluate the feasibility of the use oral ibuprofen suspension (OIS) in the treatment of patent ductus arteriosus (PDA) in premature infants. Premature infants (≤ 35 weeks) age 2 to 7 days who suffered from respiratory distress and had been diagnosed with PDA were included in this study. Color Doppler echocardiography (ECHO) was used to measure the internal ductal diameter, pressure gradient, and the ratio of left atrial to aortic root diameters (La/Ao). Infants were randomly assigned to one of two groups: group I received three doses of intravenous (IV) indomethacin (0.2 mg/kg at 12-hour intervals) and group O received an initial dose of OIS (10 mg/kg), followed by two doses of 5 mg/kg each, after 24 and 48 hours. A follow-up ECHO was done after treatment by the same pediatric cardiologist who was blinded to the assignment of the study groups. Changes in blood platelet count, hematocrit, blood urea nitrogen, and creatinine were compared between groups. In total, 78 premature infants were screened: 21 had been diagnosed with PDA. Infants in group I (n = 9) and group O (n = 12) did not differ in birthweight (1884 ± 485 versus 1521 ± 398 g [mean ± SD]; p = 0.13), gestational age (32.9 ± 1.6 versus 31.2 ± 2.5 weeks; p = 0.07), internal diameter of PDA (2.3 ± 0.5 versus 2.1 ± 0.5 mm; p = 0.34), pressure gradient across PDA (12.83 ± 6.46 versus 11.11 ± 4.5 mm Hg; p = 0.48), and La/Ao ratio (1.26 ± 0.21 versus 1.17 ± 0.12; p = 0.25). Closure of PDA was achieved in 78% (seven of nine) of infants in group I and in 83% (10 of 12) of infants in group O. Comparisons of laboratory changes following treatment in group I and group O were as follows: decrease in hematocrit (-6.5 ± 6.6 versus -1.2 ± 4.2; p = 0.04) and in platelet count (-54 ± 67 versus -1 ± 53 × 10³/μL; p = 0.24), and increase in blood urea nitrogen (16.4 ± 16.4 versus 2.1 ± 17.4 mg/dL; p = 0.06) and serum creatinine (0.12 ± 0.22 versus -0.06 ± 0.19 mg/dL; p = 0.13). Two infants in group I had severe pulmonary hemorrhage, whereas there were none in the group O. Oral ibuprofen could be an easy-to-administer and efficacious alternative in the treatment of PDA.

KEYWORDS

Patent ductus arteriosus (PDA) - indomethacin - oral ibuprofen - randomized trial - preterm infants - renal function

REFERENCES

• 1 Hermes-DeSantis E R, Clyman R I. Patent ductus arteriosus: pathophysiology and management.  J Perinatol. 2006;  26 S14-S18
• 2 Clyman R I. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.  J Pediatr. 1996;  128 601-607
• 3 Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.  Cochrane Database Syst Rev. 2005;  4 CD003481
• 4 Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.  Cochrane Database Syst Rev. 2004;  1 CD003480
• 5 O'Donovan D J, Baetiong A, Adams K et al.. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.  J Perinatol. 2003;  23 286-290
• 6 Thomas R L, Parker G C, Van Overmeire B, Aranda J V. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.  Eur J Pediatr. 2005;  164 135-140
• 7 Dani C, Bertini G, Pezzati M et al.. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter randomized study.  Pediatrics. 2005;  115 1529-1535
• 8 Chemtob S, Baharry K, Rex J, Verma D R, Aranda J V. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets.  Stroke. 1990;  21 777-784
• 9 Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trail at Ramathibodi Hospital.  J Med Assoc Thai. 2002;  85(suppl 4) S1252-S1258
• 10 Skinner J. Suggested grading of ductal shunt into mild, moderate and severe. In: Skinner J, Alverson D, Hunter S Echocardiography for the Neonatologist. 7th ed. London, UK; Churchill Livingstone 2000
• 11 Van Overmeire B, Smets K, Lecoutere D et al.. A comparison of ibuprofen and indomethacin for closure of PDA.  N Engl J Med. 2000;  343 674-681
• 12 Lesko S M, Mitchell A A. The safety of acetaminophen and ibuprofen among children younger than two years old.  Pediatrics. 1999;  104 e39
• 13 Raju N V, Bharadwa J RA, Thomas R, Kondure G G. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia, a pilot study.  J Perinatol. 2000;  20 13-16
• 14 Gersony W M, Peckham G J, Ellison R C, Meittinen O S, Nadas A S. Effect of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.  J Pediatr. 1983;  102 895-906
• 15 Mahony L, Carnero V, Heyman M A et al.. Prophylactic indomethacin therapy for PDA in very low birth weight infants.  N Engl J Med. 1982;  306 506-510
• 16 Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli F F. Effect of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus.  J Pediatr. 1999;  135 733-738
• 17 Little D C, Pratt T C, Blalock S E, Krauss D R, Cooney D R, Custer M D. Patent ductus arteriosus in micropremies and full-term infants. The relative merits of surgical ligation versus indomethacin treatment.  J Pediatr Surg. 2003;  38 492-496